NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/24/2024
Back to search
Official data from USPTO
KYFORA BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KYFORA BIO
ST13
US500000097372045Class
5, 42
Filing
97372045
Registration
7626969
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
12/24/2024
Trademark type
Word
Nice classes
5, 42
Filing date
04/20/2022
Registration date
12/24/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/24/2024
Last transaction
12/24/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-05-00
First use in commerce
2024-05-00
Drawing code
4
Owner type
16
Owner location
Horsham, PA
Examiner
EISNACH, MICHAEL
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
KYFORA BIO, LLC
The Ott Group, Inc.
Representatives
David M. Tener, Esq. CAESAR RIVISE, PC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for medical use for research and for genetic diagnosticsfor the discoverydevelopment and delivery of cell and gene therapies for treating genetic diseases; Diagnostic agents for medical use for research and for genetic diagnostics; Reagents for medical use for research and for genetic diagnostics; Chemical and biochemical diagnostic reagent test kits for medical and clinical use comprised of medical diagnostic preparationsagents and reagents for use in disease testing; Medicines for the treatment of genetic diseases
Class 42
Analyses in the field of molecular biology; Analysis of the chemical composition of liquids; Chemical analysis; Chemical and biochemical analyses; Chemical engineering services; Chemical laboratory services; Chemical research; Chemical technology research; Computer-aided scientific testing of DNA samples for diagnostic purposes; Scientific research in the nature of conducting clinical trials for others for pharmaceutical and genetic products; Consultancy in the field of pharmaceutical research; Consulting in relation to research and development of transfections agents and agentsreagents and chemicals and biochemicals used in the field of genetics; Development of new products in the field of gene therapy; Development of pharmaceutical preparations and medicines; Development of pharmaceutical products; Testing and evaluation of chemicals; Genetic analyses for scientific research purposes; Industrial packaging design services; Inspection of pharmaceutical products; Laboratory research in the field of genetics; Laboratory research services concerning pharmaceutical products; Pharmaceutical product development services; Pharmaceutical research services; Provision of information concerning the results of clinical trials for pharmaceutical products; Quality evaluation of pharmaceutical products; Research and development for the pharmaceutical industry; Research and development of new products for third parties; Research in the field of pharmaceutical products; Scientific analyses and research in the field of transfection; Scientific development of transfection agents; Scientific research for medical purposes in the field of genetics and genetic engineering; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of medicines; Scientific testing services in the field of genetics; Services of a genetic research laboratorygenetic testing for scientific research purposes and development of gene therapies for medical purposes; Software design and computer software design in the field of scientific research and genetic analyses; Structural and functional analysis of genomes; Testing of chemical products; Testing on pharmaceutical products
Publications
History of USPTO decisions and trademark events.
38 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/03/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/03/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/02/2024
IUAF
USE AMENDMENT FILED
11/21/2024
EISU
TEAS STATEMENT OF USE RECEIVED
11/21/2024
DPCC
DIVISIONAL PROCESSING COMPLETE
07/18/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/18/2024
EX1G
SOU EXTENSION 1 GRANTED
07/18/2024
DRRR
DIVISIONAL REQUEST RECEIVED
07/18/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/28/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/24/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/24/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/24/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
05/22/2024
EXT1
SOU EXTENSION 1 FILED
05/21/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/21/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/02/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/02/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/27/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/26/2023
PUBO
PUBLISHED FOR OPPOSITION
09/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/21/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/14/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
05/15/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
05/15/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/14/2023
GNRT
NON-FINAL ACTION E-MAILED
02/14/2023
CNRT
NON-FINAL ACTION WRITTEN
02/14/2023
DOCK
ASSIGNED TO EXAMINER
02/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/26/2022
NWAP
NEW APPLICATION ENTERED
04/23/2022
Continuous trademark protection
Get notified about every new filing that threatens KYFORA BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.